Out-Licensing Opportunities

Description

We are pleased to offer several innovative PEG and PEGylation technologies for out-licensing as sole and non-exclusive licenses.

JenKem Technology’s Out-Licensing Opportunities	US Patent Number	China Patent Number
Conjugate of polyethylene glycol and naloxone and pharmaceutical composition and use thereof	US8962647	ZL201210040133.2
Dasatinib and nonlinear configuration polyethylene glycol conjugate	US9566344	ZL201310241908.7
Stearic acid derivatives and oleic acid derivatives of multi-arm polyethylene glycol	US9890245	ZL201410717479.0
3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof	US9834530	ZL201410714845.7
Polyethylene glycol-cactus oligopeptide bonding rapamycin derivatives	US10098870	ZL201410715522.X
Conjugate of dezocine and polyethylene glycol	US10596268	ZL201611199383.5
Pegylated thioxanthone photoinitiator and photosensitive resin composition	US2020/0131147	ZL201810040940.1

If you are interested in more details about JenKem Technology’s out-licensing opportunities, please contact us at tech@jenkemusa.com.

Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified, and adheres to ICH Q7 guidelines for GMP manufacture. The production of JenKem® PEGs is back-integrated to in-house polymerization from ethylene oxide, enabling facile traceability for regulated customers. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.